跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
R9-13
首页
药物
R9-13
R9-13
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Extreme environment surfactant compositions comprising hydrolysis resistant organomodified disiloxane surfactants
US 7645720 B2
申请人: MOMENTIVE PERFORMANCE MAT INC
优先权: 2005
CN
EP
US
11 件公开
Organic compound, optical device, light-emitting device, light-emitting apparatus, electronic device, and lighting device
US 12421201 B2
申请人: SEMICONDUCTOR ENERGY LAB
优先权: 2019
CN
US
WO
5 件公开
Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device
US 11665960 B2
申请人: SEMICONDUCTOR ENERGY LAB
优先权: 2017
CN
US
4 件公开
Use of polynuclear phenolic compounds as stabilisers
US 8409474 B2
申请人: LANGE ARNO
优先权: 2006
US
4 件公开
Pre-assembled, protected, chemically stable, chemoselective linkers
US 12037311 B2
申请人: COWPER SCIENCES INC
优先权: 2016
CN
US
3 件公开
(Meth)acrylate derivative, polymer and photoresist composition having lactone structure, and method for forming pattern by using it
US 2009023878 A1
申请人: NEC CORP
优先权: 1998
US
3 件公开
Cyclosporin derivatives for treating ocular and dermal diseases and conditions
US 8716238 B2
申请人: GARST MICHAEL E
优先权: 2009
US
3 件公开
Use of metal complex compounds as oxidation catalysts
US 2009068282 A1
申请人: SCHLINGLOFF GUNTHER
优先权: 2001
US
2 件公开
Triazolo compounds as MMP inhibitors
US 6849637 B2
申请人: WARNER LAMBERT CO
优先权: 2002
US
2 件公开
Oxo-azabicyclic compounds
US 6747147 B2
申请人: WARNER LAMBERT CO
优先权: 2003
US
2 件公开
US 2003216402 A1
申请人: GAUDILLIERE BERNARD
优先权: 2003
US
第 1 / 3 页
上一页
下一页
药物
反馈